Results 141 to 150 of about 6,584,582 (379)

To publish or not to publish [PDF]

open access: yesNature, 1990
Paul G. McDonough   +3 more
openaire   +2 more sources

Publisher's Comment

open access: yesJournal of Biocommunication, 2016
This Publisher's Comment provides an overview of the content for issue 43-1 of the Journal of Biocommunication. This publication represents our first issue of 2019, and it is our sixth issue designed for our new mixed publishing format.Journal Management Board for the ...
openaire   +16 more sources

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

Mentorship program to elevate journal quality and rankings in Indonesia: a case study [PDF]

open access: yesScience Editing
This article explores the best practices of mentorship programs in all journals at Universitas Airlangga. The university has established a journal mentoring team, as mandated by the rector’s regulation, which is responsible for guiding journals through ...
Ferry Efendi   +4 more
doaj   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

The influence of residential facilities on depression and frailty of the elderly in rural China: Evidence from the China health and retirement longitudinal study

open access: yesFrontiers of Architectural Research
In the context of rural revitalization and the increasing prevalence of aging population, the mental health of older adults in rural China has become an issue of widespread social concern.
Zhenhua Zheng   +4 more
doaj   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Five Minutes with Tim Gowers and Tyler Neylon: “The boycott has made Elsevier more concerned about its public image” [PDF]

open access: yes, 2012
Earlier this year Tim Gowers sparked debate about the future of academic publishing when he declared his intentions to boycott Elsevier. With Tyler Neylon’s work on the Cost of Knowledge website, the pair discuss how they made a splash in the comfy world
Blog Admin, Impact of Social Sciences,   +2 more
core  

Home - About - Disclaimer - Privacy